Tsukasa Kobayashi

Mr. Tsukasa Kobayashi


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
YOYuki Ohta
Yuki Ohta
MTMitsuko Takenaga
Mitsuko Takenaga
AHAkemi Hamaguchi
Akemi Hamaguchi
MOMasanori Ootaki
Masanori Ootaki
YTYuko Takeba
Yuko Takeba
NMNaoki Matsumoto
Naoki Matsumoto
Adipose tissue contains multipotent cells known as adipose-derived stem/stromal cells (ASCs), which have therapeutic potential for various diseases. Although the demand for adipose tissue for research use remains high, no adipose tissue bank exists. In this study, we attempted to isolate ASCs from cryopreserved adipose tissue with the aim of developing a banking system. ASCs were isolated from fresh and cryopreserved adipose tissue of rats and compared for proliferation (doubling time), differentiation capability (adipocytes), and cytokine (hepatocyte growth factor and vascular endothelial growth factor) secretion. Finally, ASCs (2.5 × 106) were intravenously infused into rats with spinal cord injury, after which hindlimb motor function was evaluated. Isolation and culture of ASCs from cryopreserved adipose tissue were possible, and their characteristics were not significantly different from those of fresh tissue. Transplantation of ASCs derived from cryopreserved tissue significantly promoted restoration of hindlimb movement function in injured model rats. These results indicate that cryopreservation of adipose tissue may be an option for clinical application.

20 April 2022 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
TKTsukasa Kobayashi
Tsukasa Kobayashi
YTYuko Takeba
Yuko Takeba
YOYuki Ohta
Yuki Ohta
MOMasanori Ootaki
Masanori Ootaki
KKKeisuke Kida
Keisuke Kida
NMNaoki Matsumoto
Naoki Matsumoto

19 March 2022 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
TKTsukasa Kobayashi
Tsukasa Kobayashi
YTYuko Takeba
Yuko Takeba
YOYuki Ohta
Yuki Ohta
MOMasanori Ootaki
Masanori Ootaki
KKKeisuke Kida
Keisuke Kida
NMNaoki Matsumoto
Naoki Matsumoto

19 August 2021 in Research Square
Verified
Preprint
Open access
PDF file
TKTsukasa Kobayashi
Tsukasa Kobayashi
YTYuko Takeba
Yuko Takeba
YOYuki Ohta
Yuki Ohta
MOMasanori Ootaki
Masanori Ootaki
KKKeisuke Kida
Keisuke Kida
NMNaoki Matsumoto
Naoki Matsumoto
Prenatal glucocorticoid (GC) is clinically administered to pregnant women who are at risk of preterm birth for maturation of cardiopulmonary function. Preterm and low-birth-weight infants often experience liver dysfunction after birth because the liver is immature. However, the effects of prenatal GC administration on the liver remain unclear. We aimed to investigate the effects of prenatal GC administration on the maturation of liver hepatocytes in preterm rats.Dexamethasone (DEX) was administered to pregnant Wistar rats on gestational days 17 and 19 before cesarean section. Real time-polymerase chain reaction (RT-PCR) was performed to determine the mRNA levels of albumin, HNF4α, HGF, Thy-1, cyclin B, and CDK1 in the liver samples. Immunohistochemical staining and enzyme-linked immunosorbent assay were performed to examine protein production.The hepatocytes enlarged because of growth and prenatal DEX administration. Albumin, HNF4α, and HGF levels increased secondary to growth and prenatal DEX administration. The levels of the cell cycle markers cyclin B and CDK1 gradually decreased during growth and with DEX administration.The results suggest that prenatal GC administration leads to hepatocyte maturation via expression of HNF4α and HGF in premature fetuses.

1 May 2023
Verified
Conference Paper
Closed access
KKK. Kase
K. Kase
SWS. Watanabe
S. Watanabe
KSKeigo Saeki
Keigo Saeki
TKTsukasa Kobayashi
Tsukasa Kobayashi
YTYoshimichi Takeda
Yoshimichi Takeda
SYS. Yano
S. Yano

29 July 2021 in Research Square
Verified
Preprint
Open access
PDF file
TKTsukasa Kobayashi
Tsukasa Kobayashi
YTYuko Takeba
Yuko Takeba
YOYuki Ohta
Yuki Ohta
MOMasanori Ootaki
Masanori Ootaki
KKKeisuke Kida
Keisuke Kida
NMNaoki Matsumoto
Naoki Matsumoto
Prenatal glucocorticoid (GC) is clinically administered to pregnant women at risk of preterm birth for maturation of the cardiopulmonary function. Preterm and low birth weight infants often experience liver dysfunction after birth because the liver is immature. However, the effects of prenatal GC administration on the liver remain unclear. We aimed to investigate the effects of prenatal GC administration regarding maturity of the liver in preterm rats. Dexamethasone (DEX) was administered to pregnant Wistar rats on gestational day 17 and 19 before cesarean section. Real time polymerase chain reaction (RT-PCR) was then used to analyze the mRNA levels (albumin, HNF4α, HGF, Thy-1, cyclin B, and CDK1) in the liver samples. Immunohistochemical staining and enzyme-linked immunosorbent assay (ELISA) were used to analyze protein production. Hepatocyte size enlarged because of growth and administration of prenatal DEX. Albumin, HNF4α, and hepatocyte growth factor (HGF) increased secondary to growth and administration of prenatal DEX. Cell cycle markers, cyclin B, and CDK1 gradually decreased during growth and by administration of DEX. These results suggest that prenatal GC administration achieves hepatocyte maturation via expression of HNF4α and HGF in premature fetuses.